In the recent twist to the SEBI-Sahara struggle, sources revealed that the market regulator had sent a team of 20 officials to eastern Uttar Pradesh and eastern Bihar to identify genuine Sahara OFCD (Optionally Fully Convertible Debentures) investors.
The Supreme Court lashes out strongly against the government's role in the CBI investigation into coal block allocations. The apex court has said that political interference in CBI's work has caused a "massive breach of trust".
Jyotivardhan Jaipuria, MD & HoR, Bank of America Merrill Lynch (BofA-ML) states that single digit earnings growth is expected in FY14. Higher taxes will hit FY14 earnings by 1-1.5%.
Atsi Sheth, Vice President- Sovereign Risk Group at Moody's Investors Service spoke to Bloomberg TV India and expressed confidence in revival of India's infrastructure story. Moody's believes that increased private investment would benefit India's sovereign credit profile.
Tirthankar Dash, COO Consultancy Business at Quantum 360 talks to Bloomberg TV India's Harsha Subramaniam about consumption focus on aspirants, in this segment of In Business.
Tune in to this exclusive interview with James Allison, IR & MA at Unilever, as he speaks to Bloomberg TV India and he shares his outlook on Unilever hiking its stake to 75% in HUL.
Hindustan Unilever is likely to see a 14% year-on-year increase in PAT at Rs.760 crore versus Rs.664 crore when it announces its fourth-quarter earnings today.
IL& FS Group CEO Vibhav Kapoor speak about the markets, corporate and economic scenario in India. He pointed out that sentiment is becoming a little more positive as compared to a few months ago. Tune in to this segment of Market Guru to further hear his views on earnings and rate cuts.
Biocon had yet another stellar quarter. The pharma major delivered a strong performance driven by an evolving product portfolio and research services.Biocon CMD Kiran Mazumdar-Shaw said, "Our research services business performed well in Q4 and branded formulations revenues have also jumped 34%."
Minority investors divided over changes at ICICI bank
Fund managers seek clarity on governance & leadership for investment decisions
Kochhar's fully paid leave raises questions
Proxy advisory firm raises questions on remuneration
Will issue 5.1% equity shares worth Rs 746 Cr to investors, priced at Rs 1,661/sh
IIFL's wealth management business valued at Rs 14,600 Cr
Investors include Amansa holdings, General Atlantic Singapore & HDFC Standard Life
Gets final USFDA approval for Generic Sustiva
U.S. Sales stood at approximately $105 Mn in a 12 month period, ending in April 2018
Nerolac to enter share purchase agreement with RAK paints in Bangladesh
Will acquire 55% paid up equity share capital in RAK paints for Rs 45.8 Cr
Acquisition to be complete by 31st July 2018
UPL consortium said to be in talks to buy platform's agri pesticide unit Arysta Lifescience
UPL to team up with Abu Dhabi investment authority for Arysta Lifescience
UPL group's talks for Arysta Lifescience unit said to be in advanced stages